| P2093 | author name string | H Albrecht | |
| | G Sauter | |
| | J Köllermann | |
| | C Bokemeyer | |
| | R Simon | |
| | T Schlomm | |
| | H Huland | |
| | M Graefen | |
| | W Wilczak | |
| P2860 | cites work | The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website | Q24645514 |
| | Mechanisms of regulating the Raf kinase family | Q28183716 |
| | Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF | Q28251989 |
| | Cancer statistics, 2005 | Q29617572 |
| | BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis | Q29617585 |
| | BRAF activation initiates but does not maintain invasive prostate adenocarcinoma | Q33392719 |
| | Proliferation and survival molecules implicated in the inhibition of BRAF pathway in thyroid cancer cells harbouring different genetic mutations. | Q33514138 |
| | Update on epidermal growth factor receptor mutations in non-small cell lung cancer | Q34594740 |
| | Combinatorial activities of Akt and B-Raf/Erk signaling in a mouse model of androgen-independent prostate cancer | Q35080706 |
| | BRAF(E600) in benign and malignant human tumours | Q36921234 |
| | Therapeutic strategies for targeting BRAF in human cancer | Q37161265 |
| | BRAF and KRAS mutations in prostatic adenocarcinoma | Q38510108 |
| | Inhibition of growth and invasive ability of melanoma by inactivation of mutated BRAF with lentivirus-mediated RNA interference. | Q40543154 |
| | High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma | Q44387406 |
| | A comparison of five immunohistochemical biomarkers and HER‐2/neu gene amplification by fluorescence in situ hybridization in white and Korean patients with early‐onset breast carcinoma | Q44611360 |
| | Lack of BRAF activating mutations in prostate adenocarcinoma: a study of 93 cases | Q46261964 |
| | Assessing EGFR mutations | Q46923477 |
| | Microsatellite instability, mismatch repair deficiency, and BRAF mutation in treatment-resistant germ cell tumors. | Q51766708 |
| | High throughput DNA sequence variant detection by conformation sensitive capillary electrophoresis and automated peak comparison. | Q51956069 |
| | BRAF Mutation in Papillary Thyroid Carcinoma | Q73276150 |
| | Predominance of high-grade pathway in breast cancer development of Middle East women | Q81601035 |
| | Oncogenic BRAF is required for tumor growth and maintenance in melanoma models | Q82310241 |
| P433 | issue | 4 | |
| P921 | main subject | prostate cancer | Q181257 |
| P304 | page(s) | 729-732 | |
| P577 | publication date | 2010-07-01 | |
| P1433 | published in | Oncology Letters | Q20640514 |
| P1476 | title | Activating BRAF gene mutations are uncommon in hormone refractory prostate cancer in Caucasian patients | |
| P478 | volume | 1 | |